Birdwatch Note
2024-08-01 20:25:51 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Não é verdade que a boxeadora argelina Imane Khelif seja um homem! Khelif sofre de hiperandrogenismo, um distúrbio que causa níveis de testosterona acima do normal, mas passou por tratamento! https://www.e-farsas.com/imane-khelif-participou-do-boxe-feminino-nas-olimpiadas-mesmo-sendo-uma-mulher-trans.html
Written by F0A34371225B0A87BCA11252BF8EDBC09A9635F322060ABE61BE8E428EB5785E
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1819047570414444594
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1819107295579480120
- noteId - 1819107295579480120
- participantId -
- noteAuthorParticipantId - F0A34371225B0A87BCA11252BF8EDBC09A9635F322060ABE61BE8E428EB5785E Participant Details
- createdAtMillis - 1722543951304
- tweetId - 1819047570414444594
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Não é verdade que a boxeadora argelina Imane Khelif seja um homem! Khelif sofre de hiperandrogenismo, um distúrbio que causa níveis de testosterona acima do normal, mas passou por tratamento! https://www.e-farsas.com/imane-khelif-participou-do-boxe-feminino-nas-olimpiadas-mesmo-sendo-uma-mulher-trans.html
Note Ratings
rated at | rated by | |
2024-08-04 20:34:35 -0500 | Rating Details | |
2024-08-02 09:46:23 -0500 | Rating Details | |
2024-08-02 07:41:47 -0500 | Rating Details | |
2024-08-02 06:28:56 -0500 | Rating Details | |
2024-08-02 05:46:59 -0500 | Rating Details | |
2024-08-01 17:31:08 -0500 | Rating Details | |
2024-08-01 17:11:19 -0500 | Rating Details | |
2024-08-01 17:08:01 -0500 | Rating Details | |
2024-08-01 16:42:01 -0500 | Rating Details | |
2024-08-01 16:39:36 -0500 | Rating Details | |
2024-08-01 16:04:16 -0500 | Rating Details | |
2024-08-01 15:54:15 -0500 | Rating Details | |
2024-08-01 15:48:09 -0500 | Rating Details | |
2024-08-01 15:47:16 -0500 | Rating Details | |
2024-08-01 15:41:43 -0500 | Rating Details | |
2024-08-02 01:00:41 -0500 | Rating Details |